Seeing Is Believing

Currently out of the existing stock ratings of Matt Bottomley, 21 are a HOLD (39.62%), 19 are a BUY (35.85%), 13 are a SELL (24.53%).
Analyst Matt Bottomley, currently employed at CANACCORD, carries an average stock price target met ratio of 43.75% that have a potential upside of 26.75% achieved within 135 days.
Matt Bottomley’s has documented 78 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ACB, Aurora Cannabis at 08-Aug-2024.
Analyst best performing recommendations are on APHA (APHRIA).
The best stock recommendation documented was for APHA (APHRIA) at 4/13/2021. The price target of $18 was fulfilled within 17 days with a profit of $3.15 (21.21%) receiving and performance score of 12.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Aug-2024
2 years 1 months 29 days ago
(08-Aug-2024)
1/2 (50%)
$-4.52 (-84.96%)
487
Hold Since 23-Sep-2020
$2
$-0.83 (-29.33%)
3 years 9 months 9 days ago
(28-Dec-2022)
2/3 (66.67%)
$-6.47 (-76.39%)
718
Buy Since 21-Sep-2022
$3
$-0.92 (-23.47%)
$40.5
4 years 16 days ago
(21-Sep-2022)
5/10 (50%)
$-10 (-76.92%)
133
Hold Since 17-May-2022
$80
4 years 4 months 20 days ago
(17-May-2022)
2/3 (66.67%)
$11.4 (16.62%)
8
Hold
4 years 4 months 21 days ago
(16-May-2022)
4/7 (57.14%)
$6.37 (31.42%)
9
What Year was the first public recommendation made by Matt Bottomley?